Akums Drugs and Pharmaceuticals (BOM:544222) Revenue : ₹28,292 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals Revenue?

Akums Drugs and Pharmaceuticals's revenue for the three months ended in Dec. 2024 was ₹10,104 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₹28,292 Mil. Akums Drugs and Pharmaceuticals's Revenue per Share for the three months ended in Dec. 2024 was ₹66.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹185.19.

During the past 12 months, the average Revenue per Share Growth Rate of Akums Drugs and Pharmaceuticals was 238.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Akums Drugs and Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 14.30% per year. The lowest was 14.30% per year. And the median was 14.30% per year.

Akums Drugs and Pharmaceuticals Revenue Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals Revenue Chart

Akums Drugs and Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Revenue

26,951.67

36,468.34

34,747.64

40,196.82

Akums Drugs and Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Revenue	Get a 7-Day Free Trial			11,812.52	10,828.35	7,857.09	10,330.87	10,104.11

Competitive Comparison of Akums Drugs and Pharmaceuticals's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akums Drugs and Pharmaceuticals's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's Revenue distribution charts can be found below:

* The bar in red indicates where Akums Drugs and Pharmaceuticals's Revenue falls into.

Save Embed

;

Save Embed

;

Akums Drugs and Pharmaceuticals Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28,292 Mil.

Akums Drugs and Pharmaceuticals (BOM:544222) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Akums Drugs and Pharmaceuticals Revenue Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Akums Drugs and Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (BOM:544222) » Definitions » Revenue

Traded in Other Exchanges

AKUMS:India

Address

Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083

Website

https://www.akums.in

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines